Specific Inhibition of SRC Kinase Impairs Malignant Glioma Growth In Vitro and In Vivo
Malignant glioma is a severe cancer with a poor prognosis. Local occurrence and rare metastases of malignant glioma make it a suitable target for gene therapy. Several studies have demonstrated the importance of Src kinase in different cancers. However, these studies have focused mainly on Src-defic...
Main Authors: | Hanna Stedt, Laura Alasaarela, Haritha Samaranayake, Jere Pikkarainen, Ann-Marie Määttä, Ivana Kholová, Aaron S. Parker, Seppo Ylä-Herttuala |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116300786 |
Similar Items
-
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
by: Matsutani Tomoo, et al.
Published: (2012-10-01) -
小鼠肝细胞SMAC基因特异干扰载体的构建及慢病毒包装
by: WU Fan
Published: (2014-05-01) -
Structural and functional characterization of the divergent Entamoeba Src using Src inhibitor-1
by: Luilli López-Contreras, et al.
Published: (2017-10-01) -
Endocytosis and the Src family of non-receptor tyrosine kinases
by: Reinecke James, et al.
Published: (2014-05-01) -
Phosphorylation of Unique domains of Src family kinases
by: Irene eAmata, et al.
Published: (2014-06-01)